Form 4 | Impact Biomedical's Director Chan Heng Fai Ambrose sold 351,555 Shares.

Filings Track
08 Apr
Impact Biomedical Inc. (Ticker: IBO) Director Chan Heng Fai Ambrose sold 351,555 shares of common stock on April 3, 2025, at an average sale price of $0.495. This action indicates a lack of confidence in the company's current stock price by a member of the senior management. Investors should closely monitor this as it may signal a bearish outlook from the company director.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10